Bougen-Zhukov, N.; Decourtye-Espiard, L.; Mitchell, W.; Redpath, K.; Perkinson, J.; Godwin, T.; Black, M.A.; Guilford, P.
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. Cancers 2022, 14, 1609.
https://doi.org/10.3390/cancers14071609
AMA Style
Bougen-Zhukov N, Decourtye-Espiard L, Mitchell W, Redpath K, Perkinson J, Godwin T, Black MA, Guilford P.
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. Cancers. 2022; 14(7):1609.
https://doi.org/10.3390/cancers14071609
Chicago/Turabian Style
Bougen-Zhukov, Nicola, Lyvianne Decourtye-Espiard, Wilson Mitchell, Kieran Redpath, Jacqui Perkinson, Tanis Godwin, Michael A. Black, and Parry Guilford.
2022. "E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib" Cancers 14, no. 7: 1609.
https://doi.org/10.3390/cancers14071609
APA Style
Bougen-Zhukov, N., Decourtye-Espiard, L., Mitchell, W., Redpath, K., Perkinson, J., Godwin, T., Black, M. A., & Guilford, P.
(2022). E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. Cancers, 14(7), 1609.
https://doi.org/10.3390/cancers14071609